Opinion
|
||||||||||||||
Insights
-
January 16, 2011

Over 3,000 units of Sterimar, Church & Dwight's saline nasal spray in the UK, are mistakenly released then recalled due to soil bacteria contamination of weakly pathogenic organisms
-
January 10, 2012

Glaxo anxious to sell remaining OTC brands after Prestige buys 17 US brands on block; ex-US sales likely to be fragmented.
-
January 9, 2012

Novartis follows Sanofi's playbook looks for $2-3 billion bolt-on acquisitions of OTC and vet businesses so as a gain scale.
-
January 8, 2012

Following a strong 483 warning last year emanating from the FDA inspection of its Nebraska plant Novartis has closed the plant and recalled OTC brands; many of the FDA concerns centered around faulty consumer complaint handling and follow up; consumers may wish to continue to trust store brand options, not branded products
-
December 21, 2011

J&J recalls multiple lots of Motrin IB tablets and caplets due to failed dissolution tests in later stages of their stability program; facts suggest a long standing problem in tablet compression, coating or formulation; manufacturing site in Puerto Rico operating under a consent decree
-
December 20, 2011

Prestige Brands buys 17 US OTC brands from Glaxo for £426 million, or 3.5x sales, or about 50% of the sales on the block; brands include: BC, Goody's, Beano, Ecotrin, Fiber Chocie & Tagamet. Ex-US brands and Alli remain undivested. Prestige uses debt leverage at nearly 5x EBITDA to finance transaction
Sign up for our Email Alerts
More opinions
- P&G's Masterstroke: The Teva Deal
- Charge of the "Lite" Brigade: OTC Lipitor?
- FDA Issues Regulations on Sunscreens: Will The Consumer Be Protected?
- How Well Do Companies Advertise OTC Products To Practicing Physicians?
- The Taking of Allegra 1 2 3: The 2011 Remake
- Store Brands: A Strategic Imperative for Any Retailer
More insights
- National Ad Division Goes After Retouching of Beauty Ads, Ad Age
- Beiersdorf Moves Ahead With Final Stage of Restructuring and Axes 1,000 Jobs, Cosmetics Design
- Procter & Gamble Divests Pur But Retains Philanthropic Program, Ad Age
- China Says Johnson & Johnson Should 'Practise Morality', Asia One
- Tylenol, False Patent Markings and Due Process, Pharmalot
- Glaxo Said to Get Thomas H. Lee Bid for OTC; Sanofi Interested, Bloomberg




P&G and Teva Pharma formed a strategic healthcare joint venture on Nov 3, 2011. In one masterstroke P&G has created synergies in multiple dimensions and has forged a new business model that should be the envy of the consumer healthcare industry. We recount P&G's long journey to this game-changing moment.








